Literature DB >> 17445787

Evolutionary deimmunization: an ancillary mechanism for self-tolerance?

Anne S De Groot1, Miriam Goldberg, Leonard Moise, William Martin.   

Abstract

Self-proteins in the extracellular environment are constantly sampled and processed through the Class II antigen presentation pathway. Mechanisms responsible for central and peripheral tolerance reduce the chance of autoimmune responses to these proteins. However, tolerance can and does break down, leading to the development of autoimmune disease. In a preliminary analysis, we observed that common serum proteins have fewer HLA class II-restricted T-cell epitopes than expected, when compared to random protein sequences. We therefore performed a broader analysis of human proteins to determine whether the number of T-cell epitopes in extracellular proteins is reduced in comparison with non-secreted (intracellular) proteins. Here we document fewer putative HLA class II-restricted T-cell epitopes in extracellular proteins, compared to intracellular proteins. These data suggest that the diminished presence of T-cell epitopes may reduce the potential for autoimmunity. Over evolutionary timescales, immune pressure may have resulted in alterations in the inherent T-cell immunogenic potential of autologous proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445787     DOI: 10.1016/j.cellimm.2007.02.006

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  7 in total

1.  Exploring the immunome: A brave new world for human vaccine development.

Authors:  Anne S De Groot
Journal:  Hum Vaccin       Date:  2009-12-15

2.  Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.

Authors:  Anne S De Groot; Matthew Ardito; Frances Terry; Lauren Levitz; Ted Ross; Leonard Moise; William Martin
Journal:  Hum Vaccin Immunother       Date:  2013-05-01       Impact factor: 3.452

3.  Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools.

Authors:  Anne S De Groot; Leonard Moise; Frances Terry; Andres H Gutierrez; Pooja Hindocha; Guilhem Richard; Daniel Fredric Hoft; Ted M Ross; Amy R Noe; Yoshimasa Takahashi; Vinayaka Kotraiah; Sarah E Silk; Carolyn M Nielsen; Angela M Minassian; Rebecca Ashfield; Matt Ardito; Simon J Draper; William D Martin
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

Review 4.  Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring.

Authors:  Kathy Khoy; Delphine Mariotte; Gilles Defer; Gautier Petit; Olivier Toutirais; Brigitte Le Mauff
Journal:  Front Immunol       Date:  2020-09-24       Impact factor: 7.561

5.  Of [Hamsters] and men: a new perspective on host cell proteins.

Authors:  Andres H Gutiérrez; Leonard Moise; Annie S De Groot
Journal:  Hum Vaccin Immunother       Date:  2012-09-01       Impact factor: 3.452

6.  Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflage.

Authors:  Lu He; Anne S De Groot; Andres H Gutierrez; William D Martin; Lenny Moise; Chris Bailey-Kellogg
Journal:  BMC Bioinformatics       Date:  2014-03-19       Impact factor: 3.169

7.  A High-Throughput Single-Clone Phage Fluorescence Microwell Immunoassay and Laser-Driven Clonal Retrieval System.

Authors:  Seohee Chang; Soohyun Kim; Jerome Han; Suji Ha; Hyunho Lee; Seo Woo Song; Daewon Lee; Sunghoon Kwon; Junho Chung; Junhoi Kim
Journal:  Biomolecules       Date:  2020-03-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.